PRISM BioLab Co.,LTD (TSE: 206A)
Health Care · Pharmaceuticals · JP
¥139.00
-4.79% today · -14.2% 1Y
PRISM BioLab Co.,LTD (TSE: 206A) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $32.45M and employs 35 people.
Over the last twelve months the share price has lost 14.2%, trading between 125.00 and 279.00.
Tweenvest scores PRISM BioLab Co.,LTD across four factors: quality 66/100, value 55/100. Its strongest factor is quality.
206A price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.45M
- Revenue (TTM)
- $4.54M
- P/E
- —
- EPS
- -23.73
- Dividend yield
- —
- Beta (5Y)
- 1.40
- 52-week high
- ¥279.00
- 52-week low
- ¥125.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.96M
- Employees
- 35
- Next earnings
- —
About PRISM BioLab Co.,LTD
PRISM BioLab Co., LTD. engages in the research and development of pharmaceuticals using its proprietary drug discovery platform, PepMetics Technology. The company's technology focuses on creating peptide mimetic small molecules designed to mimic α-helix or β-turn peptides, which are essential for protein-protein interactions. Through its platform, PRISM aims to discover drugs for what were previously considered 'undruggable targets,' with a pipeline including candidates for cancer and fibrotic diseases.
- ISIN
- JP3833190006
- Founded
- 2006
- Listed since
- Jul 2, 2024
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tianda Pharmaceuticals LimitedSEHK: 455 | $32.88M | HK$0.12 | +1.69% |
| Syntara LimitedASX: SNT | $32.88M | AU$0.02 | +14.29% |
| Medical Developments International LimitedASX: MVP | $32.63M | AU$0.42 | -2.35% |
| Regent Pacific Group LimitedSEHK: 575 | $32.54M | HK$0.88 | +3.55% |
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | -1.85% |
| MYUNGMOON Pharm co.,LtdKOSE: A017180 | $31.98M | ₩1,286.00 | +1.02% |
| Ambalal Sarabhai Enterprises LimitedBSE: 500009 | $31.90M | Rs40.29 | +6.25% |
| MIRA Pharmaceuticals, Inc.NasdaqCM: MIRA | $31.33M | $0.70 | -6.60% |
Figures last refreshed Oct 11, 2026.